Clinical trial
Treatment of Bacterial Vaginosis
NCT00324818 · University of Alabama at Birmingham, Other · Completed
Key facts
| NCT number | NCT00324818 |
|---|---|
| Title | Treatment of Bacterial Vaginosis |
| Official title | Therapy and Prevention for Sexually Associated Bacterial Vaginosis |
| Lead sponsor | University of Alabama at Birmingham, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bacterial Vaginosis |
| Intervention type | Drug |
| Interventions | metronidazole and azithromycin |
| Enrollment | 600 |
| Start date | Jul 1, 2002 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | May 11, 2006 |
| Last update posted | Mar 1, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: